HEAD & NECK CANCERS

Latest News

FDA Grants Fast Track Designation to MVR-T3011 in HNSCC
FDA Grants Fast Track Designation to MVR-T3011 in HNSCC

March 20th 2024

The FDA fast-tracked MVR-T3011, an intratumorally injected oncolytic virus, for treating recurrent or metastatic head and neck squamous cell cancer post-platinum chemotherapy and at least 1 prior anti-PD1/PDL1 therapy.

pCR Rate Improves With Camrelizumab Triplet
pCR Rate Improves With Camrelizumab Triplet

March 19th 2024

FDA Approves Tislelizumab for Unresectable or Metastatic ESCC
FDA Approves Tislelizumab for Unresectable or Metastatic ESCC

March 14th 2024

FDA Fast Tracks 9MW2821 for Esophageal Squamous Cell Carcinoma
FDA Fast Tracks 9MW2821 for Esophageal Squamous Cell Carcinoma

February 28th 2024

Lidocaine May be a Valuable New Tool for Cancer Treatment
Lidocaine May be a Valuable New Tool for Cancer Treatment

December 13th 2023

Video Series
Video Interviews

More News